A detailed history of Jefferies Financial Group Inc. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 163,297 shares of RVMD stock, worth $6.43 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
163,297
Previous 22,725 618.58%
Holding current value
$6.43 Million
Previous $993,000 481.47%
% of portfolio
0.05%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 08, 2025

BUY
$35.36 - $44.42 $4.97 Million - $6.24 Million
140,572 Added 618.58%
163,297 $5.77 Million
Q4 2024

Feb 14, 2025

BUY
$42.97 - $60.6 $976,493 - $1.38 Million
22,725 New
22,725 $993,000
Q1 2024

May 13, 2024

SELL
$26.56 - $33.55 $1.14 Million - $1.44 Million
-42,932 Reduced 58.53%
30,422 $980,000
Q4 2023

Feb 13, 2024

BUY
$18.35 - $34.12 $1.35 Million - $2.5 Million
73,354 New
73,354 $2.1 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.46B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.